PCMI
EVH icon

Paradigm Capital Management Inc’s Evolent Health EVH Stock Holding History

Paradigm Capital Management Inc’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-61,000
Closed -$434K – 151
2020
Q2 		$434K Buy
61,000
+30,000
+97% +$201K 0.04% 131
2020
Q1 		$168K Sell
31,000
-60,000
-66% -$536K 0.02% 145
2019
Q4 		$823K Buy
+91,000
New +$739K 0.06% 116

Other funds holding EVH

EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Paradigm Capital Management Inc's EVH Position: Q3 2020 in Review

Paradigm Capital Management Inc sold out of Evolent Health (EVH) in Q3 2020, closing a stake of 61,000 shares — an estimated $434K sold.

Paradigm Capital Management Inc first reported a position in EVH in Q4 2019 and held it in 3 quarters. The position peaked at $823K in Q4 2019. 155 funds tracked by Wall St. Rank hold EVH as of Q3 2020.

  • Paradigm Capital Management Inc reported no remaining Evolent Health position as of Q3 2020 after selling out during the quarter.
  • Paradigm Capital Management Inc sold 61,000 Evolent Health shares in Q3 2020, an estimated $434K.
  • Paradigm Capital Management Inc first reported a position in Evolent Health in Q4 2019 and held it in 3 quarters.
  • Paradigm Capital Management Inc's Evolent Health position peaked at $823K in Q4 2019.
  • 155 funds tracked by Wall St. Rank held Evolent Health as of Q3 2020.

Based on Paradigm Capital Management Inc's 13F filing for Q3 2020, filed 20 Oct 2020.